Skip to main content
TipRanks
Go Ultimate75% OFF

Nexien BioPharma (NXEN) Income Statement

6 Followers

Nexien BioPharma Income Statement

Last quarter (Q3 2025), Nexien BioPharma's total revenue was $0.00. In Q3, Nexien BioPharma's net income was $-30.09K. See Nexien BioPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementJun 24Jun 23Jun 22Jun 21Jun 20
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 155.66K$ 282.61K$ 340.74K$ 1.84M$ 2.64M
Depreciation and Amortization$ 155.66K$ 49.76K$ 563.99K$ 1.84M$ 2.64M
$ -337.00$ -233.24K$ -8.00$ -233.00$ -35.42K
$ -156.00K$ -283.00K$ -340.74K$ -750.10K$ -2.64M
$ -83.45K$ -79.29K$ -285.62K$ -1.11M$ -35.03K
$ -239.00K$ -362.00K$ -626.00K$ -1.86M$ -2.67M
$ -239.00K$ -362.00K$ -626.00K$ -1.86M$ -2.67M
Per Share Metrics
Basic EPS$ -0.00$ -0.01$ -0.01$ -0.03$ -0.05
Diluted EPS$ -0.00$ -0.01$ -0.01$ -0.03$ -0.05
Weighted Average Shares Outstanding66.19M62.33M57.86M55.40M53.91M
Weighted Average Shares Outstanding (Diluted)66.19M62.33M57.86M55.40M53.91M

Currency in USD

Nexien BioPharma Earnings and Revenue History

-6M-4M-2M00 %0.4 %0.8 %1.2 %EarningsProfit Margin20172018201920202021202220232024RevenueEarningsProfit Margin